Axsome Therapeutics, Inc. (AXSM)
146.87
+0.63
(+0.43%)
USD |
NASDAQ |
Dec 16, 16:00
146.93
+0.06
(+0.04%)
Pre-Market: 20:00
Axsome Therapeutics Accounts Payable (Quarterly): 54.23M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 21.75M |
| Fortress Biotech, Inc. | 18.77M |
| TG Therapeutics, Inc. | 112.34M |
| Karyopharm Therapeutics, Inc. | 5.392M |
| Viking Therapeutics, Inc. | 4.413M |